The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Candesartan Cilexetil API Market Research Report 2025
Synopsis
Candesartan is a drug substance for antihypertensive drugs.CAS number is 145040-37-5.
The global Candesartan Cilexetil API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Candesartan Cilexetil API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan Cilexetil API.
Report Scope
The Candesartan Cilexetil API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Candesartan Cilexetil API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candesartan Cilexetil API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tapi Teva
Jiangxi Synergy Pharma
Ningbo Menovo Pharma
Tianyu Pharma
Shaoxing Hantai Pharmaceutical
Zhejiang Huahai Pharmaceutical
Chempro Group
Suanfarma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Candesartan Cilexetil Tablets
Candesartan Cilexetil Capsule
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Candesartan Cilexetil API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Candesartan Cilexetil API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Candesartan Cilexetil API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Candesartan is a drug substance for antihypertensive drugs.CAS number is 145040-37-5.
The global Candesartan Cilexetil API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Candesartan Cilexetil API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan Cilexetil API.
Report Scope
The Candesartan Cilexetil API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Candesartan Cilexetil API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candesartan Cilexetil API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tapi Teva
Jiangxi Synergy Pharma
Ningbo Menovo Pharma
Tianyu Pharma
Shaoxing Hantai Pharmaceutical
Zhejiang Huahai Pharmaceutical
Chempro Group
Suanfarma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Candesartan Cilexetil Tablets
Candesartan Cilexetil Capsule
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Candesartan Cilexetil API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Candesartan Cilexetil API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Candesartan Cilexetil API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Candesartan Cilexetil API Market Overview
1.1 Product Definition
1.2 Candesartan Cilexetil API Segment by Type
1.2.1 Global Candesartan Cilexetil API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Candesartan Cilexetil API Segment by Application
1.3.1 Global Candesartan Cilexetil API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Candesartan Cilexetil Tablets
1.3.3 Candesartan Cilexetil Capsule
1.4 Global Market Growth Prospects
1.4.1 Global Candesartan Cilexetil API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Candesartan Cilexetil API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Candesartan Cilexetil API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Candesartan Cilexetil API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Candesartan Cilexetil API Production Market Share by Manufacturers (2019-2024)
2.2 Global Candesartan Cilexetil API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Candesartan Cilexetil API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Candesartan Cilexetil API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Candesartan Cilexetil API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Candesartan Cilexetil API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Candesartan Cilexetil API, Product Offered and Application
2.8 Global Key Manufacturers of Candesartan Cilexetil API, Date of Enter into This Industry
2.9 Candesartan Cilexetil API Market Competitive Situation and Trends
2.9.1 Candesartan Cilexetil API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Candesartan Cilexetil API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Candesartan Cilexetil API Production by Region
3.1 Global Candesartan Cilexetil API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Candesartan Cilexetil API Production Value by Region (2019-2030)
3.2.1 Global Candesartan Cilexetil API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Candesartan Cilexetil API by Region (2025-2030)
3.3 Global Candesartan Cilexetil API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Candesartan Cilexetil API Production by Region (2019-2030)
3.4.1 Global Candesartan Cilexetil API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Candesartan Cilexetil API by Region (2025-2030)
3.5 Global Candesartan Cilexetil API Market Price Analysis by Region (2019-2024)
3.6 Global Candesartan Cilexetil API Production and Value, Year-over-Year Growth
3.6.1 North America Candesartan Cilexetil API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Candesartan Cilexetil API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Candesartan Cilexetil API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Candesartan Cilexetil API Production Value Estimates and Forecasts (2019-2030)
4 Candesartan Cilexetil API Consumption by Region
4.1 Global Candesartan Cilexetil API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Candesartan Cilexetil API Consumption by Region (2019-2030)
4.2.1 Global Candesartan Cilexetil API Consumption by Region (2019-2024)
4.2.2 Global Candesartan Cilexetil API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Candesartan Cilexetil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Candesartan Cilexetil API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Candesartan Cilexetil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Candesartan Cilexetil API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Candesartan Cilexetil API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Candesartan Cilexetil API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Candesartan Cilexetil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Candesartan Cilexetil API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Candesartan Cilexetil API Production by Type (2019-2030)
5.1.1 Global Candesartan Cilexetil API Production by Type (2019-2024)
5.1.2 Global Candesartan Cilexetil API Production by Type (2025-2030)
5.1.3 Global Candesartan Cilexetil API Production Market Share by Type (2019-2030)
5.2 Global Candesartan Cilexetil API Production Value by Type (2019-2030)
5.2.1 Global Candesartan Cilexetil API Production Value by Type (2019-2024)
5.2.2 Global Candesartan Cilexetil API Production Value by Type (2025-2030)
5.2.3 Global Candesartan Cilexetil API Production Value Market Share by Type (2019-2030)
5.3 Global Candesartan Cilexetil API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Candesartan Cilexetil API Production by Application (2019-2030)
6.1.1 Global Candesartan Cilexetil API Production by Application (2019-2024)
6.1.2 Global Candesartan Cilexetil API Production by Application (2025-2030)
6.1.3 Global Candesartan Cilexetil API Production Market Share by Application (2019-2030)
6.2 Global Candesartan Cilexetil API Production Value by Application (2019-2030)
6.2.1 Global Candesartan Cilexetil API Production Value by Application (2019-2024)
6.2.2 Global Candesartan Cilexetil API Production Value by Application (2025-2030)
6.2.3 Global Candesartan Cilexetil API Production Value Market Share by Application (2019-2030)
6.3 Global Candesartan Cilexetil API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Tapi Teva
7.1.1 Tapi Teva Candesartan Cilexetil API Corporation Information
7.1.2 Tapi Teva Candesartan Cilexetil API Product Portfolio
7.1.3 Tapi Teva Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Tapi Teva Main Business and Markets Served
7.1.5 Tapi Teva Recent Developments/Updates
7.2 Jiangxi Synergy Pharma
7.2.1 Jiangxi Synergy Pharma Candesartan Cilexetil API Corporation Information
7.2.2 Jiangxi Synergy Pharma Candesartan Cilexetil API Product Portfolio
7.2.3 Jiangxi Synergy Pharma Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Jiangxi Synergy Pharma Main Business and Markets Served
7.2.5 Jiangxi Synergy Pharma Recent Developments/Updates
7.3 Ningbo Menovo Pharma
7.3.1 Ningbo Menovo Pharma Candesartan Cilexetil API Corporation Information
7.3.2 Ningbo Menovo Pharma Candesartan Cilexetil API Product Portfolio
7.3.3 Ningbo Menovo Pharma Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Ningbo Menovo Pharma Main Business and Markets Served
7.3.5 Ningbo Menovo Pharma Recent Developments/Updates
7.4 Tianyu Pharma
7.4.1 Tianyu Pharma Candesartan Cilexetil API Corporation Information
7.4.2 Tianyu Pharma Candesartan Cilexetil API Product Portfolio
7.4.3 Tianyu Pharma Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Tianyu Pharma Main Business and Markets Served
7.4.5 Tianyu Pharma Recent Developments/Updates
7.5 Shaoxing Hantai Pharmaceutical
7.5.1 Shaoxing Hantai Pharmaceutical Candesartan Cilexetil API Corporation Information
7.5.2 Shaoxing Hantai Pharmaceutical Candesartan Cilexetil API Product Portfolio
7.5.3 Shaoxing Hantai Pharmaceutical Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Shaoxing Hantai Pharmaceutical Main Business and Markets Served
7.5.5 Shaoxing Hantai Pharmaceutical Recent Developments/Updates
7.6 Zhejiang Huahai Pharmaceutical
7.6.1 Zhejiang Huahai Pharmaceutical Candesartan Cilexetil API Corporation Information
7.6.2 Zhejiang Huahai Pharmaceutical Candesartan Cilexetil API Product Portfolio
7.6.3 Zhejiang Huahai Pharmaceutical Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.6.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.7 Chempro Group
7.7.1 Chempro Group Candesartan Cilexetil API Corporation Information
7.7.2 Chempro Group Candesartan Cilexetil API Product Portfolio
7.7.3 Chempro Group Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Chempro Group Main Business and Markets Served
7.7.5 Chempro Group Recent Developments/Updates
7.8 Suanfarma
7.8.1 Suanfarma Candesartan Cilexetil API Corporation Information
7.8.2 Suanfarma Candesartan Cilexetil API Product Portfolio
7.8.3 Suanfarma Candesartan Cilexetil API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Suanfarma Main Business and Markets Served
7.7.5 Suanfarma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Candesartan Cilexetil API Industry Chain Analysis
8.2 Candesartan Cilexetil API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Candesartan Cilexetil API Production Mode & Process
8.4 Candesartan Cilexetil API Sales and Marketing
8.4.1 Candesartan Cilexetil API Sales Channels
8.4.2 Candesartan Cilexetil API Distributors
8.5 Candesartan Cilexetil API Customers
9 Candesartan Cilexetil API Market Dynamics
9.1 Candesartan Cilexetil API Industry Trends
9.2 Candesartan Cilexetil API Market Drivers
9.3 Candesartan Cilexetil API Market Challenges
9.4 Candesartan Cilexetil API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
